New insights into emergence and spread of AMR <em>Klebsiella pneumoniae</em>
Friday, July 9, 2021
3. Bacterial susceptibility & resistance, 1,5-hour Oral Session
•
S76
•
7:15 PM
>
8:45 PM
•
New insights into emergence and spread of AMR Klebsiella pneumoniae
•
3. Antimicrobial resistance
7:15 PM
•
1798
•
Hypervirulent multidrug-resistant <em>Klebsiella pneumoniae</em> among high-risk clones in India: concealed and unidentified
>
C.
Chaitra
SHANKAR (Vellore)
7:25 PM
•
2535
•
Plasmid transmission in patients colonised with more than one bacterial species harbouring extended-spectrum ß-lactamases
>
L.
Lisandra
AGUILAR-BULTET (Basel)
7:35 PM
•
2951
•
16S rRNA methyltransferases in carbapenemase-producing <em>Klebsiella pneumoniae</em> isolates in France in 2018
>
P.
Patricia
PEREZ-PALACIOS (Seville)
7:45 PM
•
1857
•
Genomic evolution of the globally disseminated multidrug-resistant <em>Klebsiella pneumoniae </em>clonal group 147
>
C.
Carla
RODRIGUES (Paris)
7:55 PM
•
1030
•
A five-year microbiological and molecular study of bacteraemias due to carbapenemase-producing <em>Klebsiella pneumoniae</em> in a Greek university hospital: replacement of KPC from VIM or NDM-producing isolates after introduction of ceftazidime/avibactam
>
M.
Matthaios
PAPADIMITRIOU-OLIVGERIS (Lausanne)
8:05 PM
•
3183
•
Ceftazidime-avibactam resistance in <em>Klebsiella pneumoniae</em> high-risk clone ST307
>
G.
Gabriele
ARCARI (Rome)
8:15 PM
•
INT99
•
Q&A/Discussion
|